Advertisement

Topics

SAGE Electrochromics, Inc. Company Profile

07:01 EDT 24th June 2018 | BioPortfolio

SAGE Electrochromics is the world’s leading manufacturer of advanced dynamic glass that can be tinted or cleared to optimize daylight and improve the human experience in buildings. SageGlass controls the sunlight and heat that enter a building, significantly reducing energy consumption while improving people’s comfort and well-being. SageGlass can reduce a building’s cooling load by 20% and HVAC requirements up to 30%. It is a smarter, more elegant solution than conventional sun controls such as mechanical window shades, blinds and louvers. The company was founded in 1989 and is headquartered near Minneapolis-St. Paul, Minn., in the heart of “the Silicon Valley of the window industry.” SAGE is a wholly owned subsidiary of Saint-Gobain of Paris, France, the world’s largest building materials company.


News Articles [114 Associated News Articles listed on BioPortfolio]

Shionogi, Sage to Partner on Developing Depression Drug in Three Asian Markets

Shionogi & Co. will partner with Sage Therapeutics to develop and commercialize Sage’s SAGE-217 to treat major depressive disorder (MDD) and other indications in Japan, Taiwan, and South Korea, ...

Shionogi, Sage to Partner on Developing Depression Drug in 3 Asian Markets

Shionogi & Co. will partner with Sage Therapeutics to develop and commercialize Sage’s SAGE-217 to treat major depressive disorder (MDD) and other indications in Japan, Taiwan and South Korea, t...

FDA Provides Expedited Path Forward For Sage’s Depression Treatment SAGE-217

Following a meeting with the U.S. Food and Drug Administration Sage Therapeutics is seeing the goal line for potential expedited approval of its major depressive disorder (MDD) and postpartum depressi...

Sage Speeds Ahead With Plans For a Short-Course Depression Drug

Sage Therapeutics has announced a potential fast path to approval for an experimental depression drug—as well as plans to treat patients with it for just two weeks until they feel relief, not ch...

Sage's major depressive disorder drug given FDA breakthrough status

Sage Therapeutics' SAGE-217, which is being assessed in a late-stage study for the treatment of patients with major depressiv -More- 

Active-Investors: Blog Exposure - Sage Therapeutics Declared Positive Results from Phase-1/2 Clinical Trial of SAGE-217 in Treatment of Insomnia

LONDON, UK / ACCESSWIRE / February 02, 2018 / Active-Investors.com has just released a free research report on Sage Therapeutics, Inc. (NASDAQ: SAGE). If you want access to this report all you need...

Sage Therapeutics' SAGE-217 shows positive effect in phase 1/2 insomnia trial

Sage Therapeutics’ sleep disorder drug SAGE-217 has yielded positive results from a phase 1/2 trial in healthy adult volunteers using a 5-hour phase advance model of insomnia using polysomnography.

WGU Offers $500,000 in Scholarships to Students Who Apply by June 30

Learn more about WGU's Sage Scholarship atwww.wgu.edu/tuition_financial_aid/scholarships/sage-scholarshipand by following @WGU on social media. Each Sage Scholarship will be applied at the rate of ...

PubMed Articles [44 Associated PubMed Articles listed on BioPortfolio]

Essential oils from Origanum vulgare and Salvia officinalis exhibit antibacterial and anti-biofilm activities against Streptococcus pyogenes.

In the present study, essential oils (EOs) extracted from oregano, sage, cloves, and ginger were evaluated for the phytochemical profile, antibacterial, and anti-biofilm activities against Streptococc...

Simultaneous pH-sensitive and oxygen-sensitive MRI of human gliomas at 3 T using multi-echo amine proton chemical exchange saturation transfer spin-and-gradient echo echo-planar imaging (CEST-SAGE-EPI).

To introduce a new pH-sensitive and oxygen-sensitive MRI technique using amine proton CEST echo spin-and-gradient echo (SAGE) EPI (CEST-SAGE-EPI).

Probability of lek collapse is lower inside sage-grouse Core Areas: Effectiveness of conservation policy for a landscape species.

Greater sage-grouse (Centrocercus urophasianus) occupy sagebrush (Artemisia spp.) habitats in 11 western states and 2 Canadian provinces. In September 2015, the U.S. Fish and Wildlife Service announce...

The SAGE Model of Social Psychological Research.

We propose a SAGE model for social psychological research. Encapsulated in our acronym is a proposal to have a synthetic approach to social psychological research, in which qualitative methods are aug...

Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015-2017.

In order to gather a global picture of vaccine hesitancy and whether/how it is changing, an analysis was undertaken to review three years of data available as of June 2017 from the WHO/UNICEF Joint Re...

Clinical Trials [28 Associated Clinical Trials listed on BioPortfolio]

Effects of Sage on Memory and Mental Performance in Alzheimer's Disease Patients

The purpose of this study is to determine the effectiveness of the herb sage in improving the mental function of individuals with Alzheimer's disease. Study hypothesis: The administration...

A Study to Assess the Pharmacodynamic Effects of SAGE-217 in Healthy Adults Using an Insomnia Model

This study will assess the pharmacodynamic effects of SAGE-217 in approximately 42 healthy adult subjects using an insomnia model.

A Study to Evaluate SAGE-217 in Patients With Parkinson's Disease of Moderate Severity

This study will assess the safety, tolerability, pharmacokinetics and efficacy of SAGE-217 in up to 30 subjects with Parkinson's Disease of Moderate Severity.

A Study to Evaluate SAGE-217 in Subjects With Essential Tremor

This study is a two-part, multicenter, Phase 2a study to evaluate the efficacy, safety, tolerability, and pharmacokinetics of SAGE-217 in up to 80 adult subjects with essential tremor.

A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression

This is a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the efficacy, safety, and pharmacokinetics of SAGE-547 Injection in adult female subjects diagn...

Companies [28 Associated Companies listed on BioPortfolio]

SAGE Electrochromics, Inc.

SAGE Electrochromics is the world’s leading manufacturer of advanced dynamic glass that can be tinted or cleared to optimize daylight and improve the human experience in buil...

SAGE Therapeutics, Inc.

Sage Therapeutics is a clinical-stage biopharmaceutical company committed to developing novel medicines to transform the lives of patients with life-altering central nervous syste...

Sage Science, Inc.

Sage Science develops game-changing instrument products for life science research and diagnostic laboratories. Sage Science is privately held. For more information visit www.sages...

Sage Science

Sage Science develops game-changing instrument products for life science research and diagnostic laboratories. Sage Science is privately held. For more information visit www.sages...

Sage Software Healthcare, LLC

For nearly 30 years, physicians have trusted Sage to deliver solutions that enable them to optimize their patients' experience while enhancing their bottom line. Sage Software Healthcare, LLC, provide...

More Information about "SAGE Electrochromics, Inc." on BioPortfolio

We have published hundreds of SAGE Electrochromics, Inc. news stories on BioPortfolio along with dozens of SAGE Electrochromics, Inc. Clinical Trials and PubMed Articles about SAGE Electrochromics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of SAGE Electrochromics, Inc. Companies in our database. You can also find out about relevant SAGE Electrochromics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...


Corporate Database Quicklinks



Searches Linking to this Company Record